Intec Pharma Ltd
(TEL Aviv Stock Exchange : NTEC)

( )
NTEC PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-2.27%166.220.4%$376.39m
AMRNAmarin Corporation Plc Sponsored ADR
-4.82%14.802.0%$117.16m
JAZZJazz Pharmaceuticals Plc
-0.17%138.252.2%$110.84m
PRGOPerrigo Co. Plc
-1.83%55.356.8%$66.11m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-5.32%112.816.3%$52.73m
MNKMallinckrodt Plc
0.76%18.6721.1%$52.38m
ICLRICON Plc
0.41%130.444.1%$44.93m
UTHRUnited Therapeutics Corporation
-0.46%106.1014.4%$38.70m
ICPTIntercept Pharmaceuticals, Inc.
1.45%106.7418.6%$37.74m
SAGESAGE Therapeutics, Inc.
-2.74%98.559.6%$36.74m
HZNPHorizon Pharma plc
-1.20%19.767.4%$34.83m
CTLTCatalent Inc
-2.95%33.232.4%$31.43m
ENDPEndo International Plc
-2.65%9.198.9%$30.16m
ZGNXZogenix, Inc.
-5.25%37.729.9%$25.34m
MDCOMedicines Company
3.83%18.6921.8%$24.70m

Company Profile

Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which focuses on developing drugs based on its proprietary Accordion Pill platform technology. Its product pipeline includes four product candidates in clinical trial stages: Accordion Pill Carbidopa/Levodopa, which is being developed for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients; Accordion Pill Zaleplon, which is being developed for the treatment of insomnia, including sleep induction and the improvement of sleep maintenance; an Accordion Pill that is being developed for the prevention and treatment of gastroduodenal and small bowel Nonsteroidal Anti-Inflammatory Drug which induces ulcers; and AP-CBD/THC, an Accordion Pill with the two primary cannabinoids contained in Cannabis sativa, cannabidiol and tetrahydrocannabinol, which is being developed for various indications including low back neuropathic pain and fibromyalgia. The company was founded by Zvi Joseph in 2000 and is headquartered in Jerusalem, Israel.